Pharma company Sudarshan Pharma Industries share price will remain in focus ahead of the company’s board meeting on June 19, 2025, to consider and approve the proposal of raising funds. According to an exchange filing, the company may raise funds by way of the issuance of equity shares or warrants. “The board of directors of the company will meet on Thursday 19th April, 2025, inter alia, to consider, evaluate and approve the proposal of raising funds by way of issuance of equity shares or any other equity-linked instruments or securities including convertible instruments, warrants etc. subject to applicable approvals,” the company told exchanges.
295% return in 1 year: Multibagger pharma stock in focus, here’s why
